Pfizer (PFE) Financials

$29.39

$-0.49 (-1.64%)

As on 06-Nov-2026 16:26EST

Market cap

$170,312 Mln

Revenue (TTM)

$63,624 Mln

P/E Ratio

42.7

P/B Ratio

Div. Yield

5.6 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	63,624.00	62,579.00	63,627.00	59,554.00	101,175.00	81,288.00
Cost of Revenue	16,940.00	16,067.00	17,851.00	24,954.00	34,344.00	30,821.00
Gross Profit	46,684.00	46,512.00	45,776.00	34,600.00	66,831.00	50,467.00
Operating Expenses	31,520.00	29,105.00	30,838.00	30,183.00	28,714.00	30,232.00
Operating Profit (EBIT)	15,164.00	17,407.00	14,938.00	4,417.00	38,117.00	20,235.00
Other Income	--	--	--	--	-217.00	4,878.00
Profit before Tax	4,260.00	7,520.00	8,023.00	1,058.00	34,729.00	24,311.00
Provision for Tax	186.00	-266.00	-28.00	-1,115.00	3,328.00	1,852.00
Profit after Tax (Net Income)	4,033.00	7,771.00	8,031.00	2,119.00	31,372.00	21,979.00
Minority Interest	-36.00	-41.00	-31.00	-39.00	-35.00	-45.00
Consolidated Profit	-1,648.00	7,771.00	8,031.00	2,119.00	31,372.00	21,979.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	89,001.00	86,476.00	88,203.00	89,288.00	95,917.00	77,463.00
Minority Interest	-36.00	299.00	294.00	274.00	256.00	262.00
Non-Current Liabilities	83,517.00	84,401.00	81,904.00	89,419.00	59,151.00	61,343.00
Current Liabilities	31,726.00	36,984.00	42,995.00	47,794.00	42,138.00	42,671.00
Total Liabilities	236,269.00	208,160.00	213,396.00	226,501.00	197,206.00	181,477.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	159,536.00	165,262.00	163,038.00	183,168.00	145,944.00	121,782.00
Current Assets	45,008.00	42,898.00	50,358.00	43,333.00	51,259.00	59,693.00
Total Assets	236,269.00	208,160.00	213,396.00	226,501.00	197,206.00	181,477.00
Total Debt*	62,671.00	67,416.00	66,993.00	75,041.00	35,829.00	38,436.00
Net Current Assets	13,283.00	5,914.00	7,363.00	-4,461.00	9,121.00	17,022.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	11,705.00	12,744.00	8,700.00	29,267.00	32,580.00
Cash Flow from Investing Activities	--	-1,351.00	2,652.00	-32,278.00	-15,783.00	-22,546.00
Cash from Financing Activities	--	-10,304.00	-17,140.00	26,066.00	-14,834.00	-9,816.00
Net Cash Inflow / Outflow	--	--	--	--	-1,350.00	218.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	0.70	1.37	1.41	0.38	5.46	3.81
Cash EPS ($)	--	2.53	2.64	1.49	6.09	4.45
Adjusted Book Value ($)	--	15.21	15.47	15.81	16.70	13.43
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	2.06	2.23	1.54	5.10	5.65
Free Cash Flow per Share ($)	--	1.60	1.72	0.85	4.53	5.18

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	5.03	5.03	1.43	25.34	20.05
ROE (%)	4.46	8.90	9.05	2.29	36.19	31.19
ROA (%)	1.67	3.69	3.65	1.00	16.57	13.09
EBIT Margin (%)	10.95	16.29	17.47	5.49	35.55	31.50
Net Margin (%)	6.34	12.42	12.62	3.56	31.07	25.51
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	1.33	-0.02	0.07	-0.41	0.24	0.95
EBIT Growth (%)	-41.21	-8.30	240.19	-90.92	40.49	201.73
Net Profit Growth (%)	-59.16	-3.24	279.00	-93.25	42.74	139.97
EPS Growth (%)	-59.38	-0.03	2.75	-0.93	0.43	1.36
Book Value Growth (%)	-4.71	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	42.69	18.22	18.84	76.72	9.38	15.50
Price / Book Value	1.97	1.64	1.72	1.82	3.07	4.40
Dividend Yield (%)	5.59	--	--	--	--	--
EV/EBITDA	16.62	11.64	10.91	23.54	7.49	11.30
Close Price ($)	28.52	24.90	26.53	28.79	51.24	59.05
High Price ($)	29.21	27.69	31.54	51.60	59.80	61.71
Low Price ($)	23.62	20.92	24.48	25.76	41.45	33.36
Market Cap ($ Cr)	170,311.63	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.67	0.78	0.76	0.84	0.37	0.50
Short term debt to equity ratio	0.03	0.04	0.08	0.12	0.03	0.03
Current Ratio	1.42	1.16	1.17	0.91	1.22	1.40
Quick Ratio	1.10	0.87	0.92	0.69	1.00	1.19
Interest Coverage	2.57	3.82	3.60	1.48	29.05	19.83

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	22.31	25.31	23.22	18.77	14.36	19.37
Asset Turnover	0.26	0.30	0.29	0.28	0.53	0.48
Receivable days	--	89.35	74.49	78.83	54.65	60.52
Inventory Days	--	244.44	215.25	140.29	95.93	101.35
Payable days	--	123.59	126.28	98.94	65.87	58.58
Cash Conversion Cycle	--	210.20	163.47	120.19	84.71	103.29

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)